CN108727408B - Pyridofuroxan energetic compound and preparation method thereof - Google Patents
Pyridofuroxan energetic compound and preparation method thereof Download PDFInfo
- Publication number
- CN108727408B CN108727408B CN201710251607.0A CN201710251607A CN108727408B CN 108727408 B CN108727408 B CN 108727408B CN 201710251607 A CN201710251607 A CN 201710251607A CN 108727408 B CN108727408 B CN 108727408B
- Authority
- CN
- China
- Prior art keywords
- reaction
- amino
- compound
- dinitropyridine
- dichloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 238000006243 chemical reaction Methods 0.000 claims abstract description 25
- URQUBZWTCDKZBI-UHFFFAOYSA-N 2,6-dichloro-3,5-dinitropyridin-4-amine Chemical compound NC1=C([N+]([O-])=O)C(Cl)=NC(Cl)=C1[N+]([O-])=O URQUBZWTCDKZBI-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000012074 organic phase Substances 0.000 claims abstract description 8
- 238000001035 drying Methods 0.000 claims abstract description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 33
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 24
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 20
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 5
- 238000001704 evaporation Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- 150000003536 tetrazoles Chemical class 0.000 abstract description 14
- JKFAIQOWCVVSKC-UHFFFAOYSA-N furazan Chemical compound C=1C=NON=1 JKFAIQOWCVVSKC-UHFFFAOYSA-N 0.000 abstract description 9
- 238000005474 detonation Methods 0.000 abstract description 6
- GZBKVUGZEAJYHH-UHFFFAOYSA-N 2-nitropyridin-3-amine Chemical compound NC1=CC=CN=C1[N+]([O-])=O GZBKVUGZEAJYHH-UHFFFAOYSA-N 0.000 abstract description 5
- 239000000706 filtrate Substances 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 238000004364 calculation method Methods 0.000 abstract description 2
- 239000000047 product Substances 0.000 abstract description 2
- 238000010025 steaming Methods 0.000 abstract 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 abstract 1
- 150000001540 azides Chemical class 0.000 abstract 1
- 238000003912 environmental pollution Methods 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000007363 ring formation reaction Methods 0.000 abstract 1
- 238000013341 scale-up Methods 0.000 abstract 1
- UWUYVPVCKDCBBP-UHFFFAOYSA-N 5-nitro-2h-1,2,5-oxadiazol-4-amine Chemical compound NC1=CNON1[N+]([O-])=O UWUYVPVCKDCBBP-UHFFFAOYSA-N 0.000 description 7
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 6
- 239000002360 explosive Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 3
- -1 tetrazolo [1,5-a ] pyridine-3-oxide Chemical compound 0.000 description 3
- PMYJGTWUVVVOFO-UHFFFAOYSA-N 4-phenyl-3-furoxancarbonitrile Chemical class N#CC1=[N+]([O-])ON=C1C1=CC=CC=C1 PMYJGTWUVVVOFO-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine group Chemical group NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical compound [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 description 2
- 238000000197 pyrolysis Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- IBTGEEMBZJBBSH-UHFFFAOYSA-N 2,6-dimethoxypyridine Chemical compound COC1=CC=CC(OC)=N1 IBTGEEMBZJBBSH-UHFFFAOYSA-N 0.000 description 1
- BLBDTBCGPHPIJK-UHFFFAOYSA-N 4-Amino-2-chloropyridine Chemical compound NC1=CC=NC(Cl)=C1 BLBDTBCGPHPIJK-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N DMSO-d6 Substances [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004774 atomic orbital Methods 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000004776 molecular orbital Methods 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
The invention discloses a pyridofuroxan energetic compound and a preparation method thereof. The method comprises the steps of realizing the ring-closing reaction of 4-amino-2, 6-dichloro-3, 5-dinitropyridine with azide and denitrification at a certain temperature, decompressing and rotary-steaming a mixture after the reaction is finished, adding water for dissolving, drying an organic phase by anhydrous sodium sulfate after extraction, filtering, decompressing and rotary-steaming a filtrate. The synthesized energetic compound has the advantages of novel structure, mild reaction conditions, no need of special devices, simple process and operation process, safe and reliable production, convenient and fast post-treatment of products and small environmental pollution, and meets the basic requirements of industrial scale-up production; the compound has the structures of tetrazole, furazan oxide and amino nitropyridine, has potential application in the field of energetic materials, and has the detonation velocity of 8754m/s in theoretical calculation.
Description
Technical Field
The invention belongs to the technical field of explosive synthesis processes, and particularly relates to a synthesis method of an energetic compound 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide.
Background
In the field of energetic materials, an energetic derivative taking a furazan oxide group as an explosive group has the following characteristics: 1) furazan oxide groups can provide relatively higher energy densities; 2) the effective oxygen content is high, and the furoxan derivative as an energetic additive can improve the oxygen balance of a system; 3) the furoxan group can endow the derivative with ring tension and high standard formation enthalpy. If one nitro group is replaced by one furazan oxide group, the density can be improved by 0.06-0.08 g/cm3The detonation velocity can be improved by 300 m/s. Furthermore, the introduction of heterocyclic systems may greatly favor combinations of their atomic orbitals over carbocyclic systems due to intramolecular perturbations, since heteroatoms play an important role in the lowest molecular orbital level. But additionallyThe stabilization effect brought by the charge density can often improve the heat resistance of the explosive and reduce the mechanical sensitivity of the explosive. The introduction of ortho amino and nitro groups on the pyridine ring to form intramolecular and intermolecular hydrogen bonds can improve the safety performance and crystal density of energetic compounds; the introduction of nitrogen-rich compounds increases the energy of the energy-containing compounds. However, researchers at home and abroad have only reported on compounds having tetrazole, furazan oxide and amino nitropyridine structures.
J Energ Mater,2005,23(2):99-106 reported that a synthetic route of an energetic compound having tetrazole, furazan oxide groups is shown as follows. The route takes 2, 6-dimethoxy pyridine as a raw material, and 7-nitrotetrazolyl [1,5-f ] furazano [4,5-b ] pyridine-1-oxide (NFP) is synthesized by nitration, hydrazine substitution, azidation and pyrolysis denitrification, and the decomposition point is about 160 ℃. The method has long synthetic route and low utilization rate of substituent groups of pyridine rings.
Chin J Chem,2013,31:1299-1304 reports a synthetic route of an energy-containing compound with a furazan oxide ring and an amino nitropyridine structure as shown in the following formula. The method takes 2-chloro-4-aminopyridine as a raw material, takes ethanol/water as a solvent, completes an azidation reaction at room temperature, and performs pyrolysis denitrification and ring closure under an acidic condition to obtain the 7-amino-6-nitro- [1,2,5] oxadiazol [3,4-b ] pyridine-1-oxide. The theoretical calculation detonation velocity of the compound is only 7.51km/s, and the detonation performance of the pyridine ring series energetic compound cannot be fully exerted.
Disclosure of Invention
The invention aims to provide a pyridofuroxan energetic compound 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide and a preparation method thereof.
In order to solve the technical problems, the invention adopts a technical scheme that:
a pyridofuroxan energetic compound (named 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide) has the following structure:
the preparation method of the compound comprises the following steps:
dissolving 4-amino-2, 6-dichloro-3, 5-dinitropyridine in an organic solvent, adding sodium azide at room temperature, and stirring for reaction for more than 30 min;
and secondly, adding a small amount of concentrated hydrochloric acid into the reaction mixed solution, heating to react for a period of time, evaporating the solvent from the mixed solution under reduced pressure after the reaction is finished, adding water to dissolve the solvent, extracting with ethyl acetate, drying the organic phase, and distilling under reduced pressure to obtain the target compound.
Wherein, in the first step, the mol ratio of the 4-amino-2, 6-dichloro-3, 5-dinitropyridine to the sodium azide is 1:2-1: 4.
In the first step, the organic solvent comprises acetonitrile, ethyl acetate, tetrahydrofuran, acetone, methanol, ethanol and a mixture thereof, preferably any one or a combination of acetonitrile, tetrahydrofuran and acetone.
In the second step, the mass of the concentrated hydrochloric acid is 1/20-1/30 of 4-amino-2, 6-dichloro-3, 5-dinitropyridine, the reaction temperature of the mixed solution is 30-50 ℃, and the reaction time is 1-3 hours.
Compared with the prior art, the invention has the following remarkable advantages: the invention synthesizes the fully-substituted pyridofuroxan energetic compound for the first time: the 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide has the advantages of simple synthesis reaction steps, mild conditions, no need of special devices, safe and reliable production, simple product post-treatment, small environmental hazard and capability of meeting the basic requirements of industrial amplification production; the compound has the structure of tetrazole, furazan oxide and amino nitropyridine, the detonation velocity is 8754m/s theoretically calculated, and the compound can be possibly used in the field of high-energy insensitive energetic materials.
The present invention is described in further detail below with reference to the attached drawing figures.
Drawings
FIG. 1 of pyridofuroxan energetic compounds of the invention1H NMR spectrum.
Detailed Description
The following detailed description of the preferred embodiments of the present invention is provided to enable those skilled in the art to more readily understand the advantages and features of the present invention, and to clearly and unequivocally define the scope of the present invention.
The 4-amino-5-nitro- [1,2,5] of the invention]Oxadiazole [3,4-e ] s]Tetrazole [1,5-a ]]Pyridine-3-oxides having the formula C5H2N8O4The structural formula is as follows:
the synthetic route of the 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide is as follows:
the invention relates to a preparation method of 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide, which comprises the following steps:
dissolving 4-amino-2, 6-dichloro-3, 5-dinitropyridine in a proper solvent, adding sodium azide at room temperature, and stirring for reaction for 1 h;
and secondly, adding a small amount of concentrated hydrochloric acid into the reaction mixed solution, heating to react for a period of time, evaporating the solvent from the mixed solution under reduced pressure after the reaction is finished, adding water to dissolve the solvent, extracting the mixture by ethyl acetate, drying an organic phase, and distilling under reduced pressure to obtain the 4-amino-5-nitro- [1,2,5] oxadiazole [3,4-e ] tetrazole [1,5-a ] pyridine-3-oxide.
Wherein, in the first step, the mol ratio of the 4-amino-2, 6-dichloro-3, 5-dinitropyridine to the sodium azide is 1:2-1:4, and the solvent for dissolving the 4-amino-2, 6-dichloro-3, 5-dinitropyridine comprises acetonitrile, ethyl acetate, tetrahydrofuran, acetone, methanol, ethanol and a mixture thereof. Wherein, the reaction solvent preferably comprises acetonitrile, tetrahydrofuran and acetone.
In the second step, the mass of the concentrated hydrochloric acid is 1/20-1/30 of 4-amino-2, 6-dichloro-3, 5-dinitropyridine, the reaction temperature of the mixed solution is 30-50 ℃, and the reaction time is 1-3 hours.
Example 1
1.26g (5mmol) of 4-amino-2, 6-dichloro-3, 5-dinitropyridine was dissolved in 15mL of acetonitrile, and 0.65g (10mmol) of sodium azide was added thereto at room temperature under stirring, followed by reaction with stirring for 30 min. 1 drop of concentrated hydrochloric acid is added into the reaction mixture, and the temperature is raised to 30 ℃ for reaction for 3 hours. After the reaction is finished, the mixed solution is decompressed and steamed, dissolved by adding water, extracted by ethyl acetate, dried and filtered by the organic phase, and the filtrate is decompressed and distilled to obtain yellow solid 4-amino-5-nitro- [1,2, 5-nitro- [1]Oxadiazole [3,4-e ] s]Tetrazole [1,5-a ]]Pyridine-3-oxide 0.89g, yield 75%. m.p.150-151 ℃ (dec.);1H NMR(DMSO-d6,400MHz):δ10.17(s,1H),9.50(s,1H);13C NMR(DMSO-d6100MHz) delta 148.96,144.27,141.87,111.17,105.06; MS (ESI) M/z:239.0(M + H), see FIG. 1.
The compound has the structures of tetrazole, furazan oxide and amino nitropyridine, the detonation velocity is calculated up to 8754m/s theoretically, and the compound has potential application in the field of high-energy insensitive energetic materials.
Example 2
1.26g (5mmol) of 4-amino-2, 6-dichloro-3, 5-dinitropyridine is dissolved in 15mL of a mixed solvent of ethyl acetate and acetone, 0.98g (15mmol) of sodium azide is added under stirring at room temperature, and the mixture is stirred and reacted for 30 min. 1 drop of concentrated hydrochloric acid is added into the reaction mixture, and the temperature is raised to 35 ℃ for reaction for 2.5 h. After the reaction, the mixture was rotary-distilled under reduced pressure, dissolved in water, extracted with ethyl acetate, the organic phase was dried, filtered, and the filtrate was distilled under reduced pressure to give 0.71g of 4-amino-5-nitro- [1,2,5] oxadiazol [3,4-e ] tetrazolo [1,5-a ] pyridine-3-oxide as a yellow solid in 60% yield.
Example 3
1.26g (5mmol) of 4-amino-2, 6-dichloro-3, 5-dinitropyridine is dissolved in 15mL of ethanol, 0.98g (15mmol) of sodium azide is added under stirring at room temperature, and the mixture is stirred and reacted for 30 min. 1 drop of concentrated hydrochloric acid is added into the reaction mixture, and the temperature is raised to 50 ℃ for reaction for 1.5 h. After the reaction, the mixture was rotary-distilled under reduced pressure, dissolved in water, extracted with ethyl acetate, the organic phase was dried, filtered, and the filtrate was distilled under reduced pressure to give 0.62g of 4-amino-5-nitro- [1,2,5] oxadiazol [3,4-e ] tetrazolo [1,5-a ] pyridine-3-oxide as a yellow solid in 52% yield.
Example 4
1.26g (5mmol) of 4-amino-2, 6-dichloro-3, 5-dinitropyridine was dissolved in 15mL of acetone, and 1.30g (20mmol) of sodium azide was added thereto at room temperature with stirring, followed by reaction with stirring for 30 min. 1 drop of concentrated hydrochloric acid is added into the reaction mixture, and the temperature is raised to 30 ℃ for reaction for 2 hours. After the reaction, the mixture was rotary-distilled under reduced pressure, dissolved in water, extracted with ethyl acetate, the organic phase was dried, filtered, and the filtrate was distilled under reduced pressure to give 0.80g of 4-amino-5-nitro- [1,2,5] oxadiazol [3,4-e ] tetrazolo [1,5-a ] pyridine-3-oxide as a yellow solid in 67% yield.
The above description is only an embodiment of the present invention, and not intended to limit the scope of the present invention, and all modifications of equivalent structures and equivalent processes performed by the present specification and drawings, or directly or indirectly applied to other related technical fields, are included in the scope of the present invention.
Claims (7)
2. a process for the preparation of a compound according to claim 1, comprising the steps of:
dissolving 4-amino-2, 6-dichloro-3, 5-dinitropyridine in an organic solvent, adding sodium azide at room temperature, and stirring for reaction for more than 30 min;
and secondly, adding a small amount of concentrated hydrochloric acid into the reaction mixed solution, heating to react for a period of time, evaporating the solvent from the mixed solution under reduced pressure after the reaction is finished, adding water to dissolve the solvent, extracting with ethyl acetate, drying the organic phase, and distilling under reduced pressure to obtain the target compound.
3. The method of claim 2, wherein in the first step, the molar ratio of 4-amino-2, 6-dichloro-3, 5-dinitropyridine to sodium azide is 1:2 to 1: 4.
4. The method of claim 2, wherein in the first step, the organic solvent comprises acetonitrile, ethyl acetate, tetrahydrofuran, acetone, methanol, ethanol, and mixtures thereof.
5. The method of claim 2, wherein in the first step, the organic solvent comprises any one or a combination of acetonitrile, tetrahydrofuran, and acetone.
6. The method according to claim 2, wherein in the second step, the mass of the concentrated hydrochloric acid is 1/20-1/30 of the mass of the 4-amino-2, 6-dichloro-3, 5-dinitropyridine.
7. The method of claim 2, wherein the reaction temperature of the mixed solution in the second step is 30 to 50 ℃ and the reaction time is 1 to 3 hours.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710251607.0A CN108727408B (en) | 2017-04-18 | 2017-04-18 | Pyridofuroxan energetic compound and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710251607.0A CN108727408B (en) | 2017-04-18 | 2017-04-18 | Pyridofuroxan energetic compound and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108727408A CN108727408A (en) | 2018-11-02 |
CN108727408B true CN108727408B (en) | 2021-04-16 |
Family
ID=63924204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710251607.0A Expired - Fee Related CN108727408B (en) | 2017-04-18 | 2017-04-18 | Pyridofuroxan energetic compound and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108727408B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113321666B (en) * | 2020-02-28 | 2022-05-20 | 南京理工大学 | Energy-containing compound based on ring-fused framework and synthetic method thereof |
CN112521402A (en) * | 2020-12-15 | 2021-03-19 | 北京理工大学 | 1,2, 4-oxadiazole [5,5] bicyclic fused ring compound and preparation method thereof |
CN115746021B (en) * | 2022-11-23 | 2024-02-13 | 中国工程物理研究院化工材料研究所 | Synthesis method of 7-amino-6-nitrobenzofuroxan and isomer thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103450108A (en) * | 2012-06-04 | 2013-12-18 | 南京理工大学 | Polyaminopolynitrobenzofuroxan metal complex and preparation method thereof |
-
2017
- 2017-04-18 CN CN201710251607.0A patent/CN108727408B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103450108A (en) * | 2012-06-04 | 2013-12-18 | 南京理工大学 | Polyaminopolynitrobenzofuroxan metal complex and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
7-氨基-6-硝基-[1,2,5]噁二唑并[3,4-b]吡啶-1-氧化物合成及性能;马丛明,等;《含能材料》;20141231;第22卷(第14期);第573页化合物3,合成路线、实验内容 * |
Preparation, characterization, and properties of 7-nitrotetrazolo[1,5-f]furazano[4,5-b]pyridine 1-oxide;My Hang V. Huynh,等;《Journal of Energetic Materials》;20060902;第23卷(第2期);第100页化合物NFP,102页NFP合成路线 * |
Also Published As
Publication number | Publication date |
---|---|
CN108727408A (en) | 2018-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108727408B (en) | Pyridofuroxan energetic compound and preparation method thereof | |
CN108424339B (en) | Preparation method of high-nitrogen two-dimensional conjugated structure doped modified ammonium nitrate explosive crystal | |
CN103694181A (en) | Synthetic method of 2, 6-diamino-3, 5-binitropyrazine-1-oxide | |
CN109627235B (en) | High-energy insensitive energetic compound and synthesis method thereof | |
CN102250007A (en) | Preparation method of 3,4-binitropyrazole | |
CN112194625B (en) | 1, 4-dinitroamino-3, 5-dinitropyrazole oxalyldihydrazine nitrate, preparation method and application thereof | |
CN114230423A (en) | CL-20/BODN eutectic explosive with low mechanical sensitivity and high detonation performance, preparation method and application | |
CN113321666B (en) | Energy-containing compound based on ring-fused framework and synthetic method thereof | |
CN114957125B (en) | Synthesis method of 4-nitro-5-nitroaminopyrazole | |
CN104693130A (en) | Synthesis method of 2,6-diamido-3,5-dinitropyrazine-1-oxide | |
Xue et al. | Methyl nitrate energetic compounds based on bicyclic scaffolds of furazan–isofurazan (isoxazole): syntheses, crystal structures and detonation performances | |
CN104496916A (en) | Preparation method of 1-oxy-2, 6-diamido-3, 5-dinitropyrazine | |
CN114315739A (en) | High-energy low-sensitivity energetic compound and preparation method thereof | |
CN115521265A (en) | High nitrogen compound and synthesis method thereof | |
CN105566244A (en) | Synthetic method for 3-(4-aminofurazan-3-radical)-4-(4-nitrofurazan-3-radical) furazan | |
CN109020906B (en) | Energetic compound and synthesis method and application thereof | |
CN110903261B (en) | Preparation method of high energy density material | |
CN113501771A (en) | Preparation method of N- (2-aminoethyl) glycine derivative | |
CN114644600B (en) | High-heat-stability high explosive and preparation method thereof | |
CN107266376B (en) | LLM-105 nitramine derivatives and preparation method thereof | |
CN104672156B (en) | 2-methyl-4-nitro-1,2,3-triazolyl-5-ammonia, and preparation method and application thereof | |
CN115340501B (en) | Energetic ionic salt based on bitriazole compounds and synthesis method thereof | |
CN115925631B (en) | Compound 3,3 ’ ,5,5 ’ -tetramino-4, 4 ’ -dinitro-1, 1 ’ -bipyrazoles and process for their preparation | |
CN110256463B (en) | 7- (3, 5-diamino-2, 4, 6-trinitrophenyl) bis furazano furoxan azepanenes | |
CN103936592B (en) | 2,4,6-trinitro--1,3-bis-(3 '-nitrostyrolene base) benzene, preparation and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210416 |
|
CF01 | Termination of patent right due to non-payment of annual fee |